Propiedad y actividad de insiders de Centessa Pharmaceuticals plc (CNTA): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $40.50 |
| Capitalización | $6.3B |
| Bolsa | NASDAQ |
| País | GB |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-06-24 | Medicxi Ventures Management (Jersey) Ltd | S-Sale | 281,162 | $10.7M |
| 2026-06-24 | INDEX VENTURES LIFE VI (JERSEY) L.P. | S-Sale | 149,421 | $5.7M |
| 2026-06-24 | HUSSAIN IQBAL J | D-Return | 5,500 | $209K |
| 2026-06-24 | HUSSAIN IQBAL J | D-Return | 221,559 | $1.3M |
| 2026-06-24 | HUSSAIN IQBAL J | D-Return | 166,779 | $1.6M |
| 2026-06-24 | HUSSAIN IQBAL J | D-Return | 100,000 | $2.0M |
| 2026-06-24 | HUSSAIN IQBAL J | D-Return | 160,000 | $1.5M |
| 2026-06-24 | HUSSAIN IQBAL J | D-Return | 100,000 | $385K |
| 2026-06-24 | HUSSAIN IQBAL J | D-Return | 170,000 | $1.4M |
| 2026-06-24 | HUSSAIN IQBAL J | D-Return | 175,000 | $3.0M |
Balance (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Caja y Equivalentes | $7.2M | $595.1M | $393.6M | $128.0M | $383.2M | $61.3M |
| Inversiones a Corto | 0 | 0 | 0 | $128.5M | $99.0M | $233.3M |
| Cuentas por Cobrar | 0 | $16.8M | $26.7M | $39.1M | $45.3M | $60.3M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $11.2M | $628.8M | $437.7M | $315.1M | $536.4M | $367.9M |
| Inmovilizado Material | 0 | $162000 | $1.2M | $13.0M | $11.8M | $10.9M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $11.7M | $629.6M | $444.3M | $360.2M | $576.8M | $687.5M |
| Cuentas por Pagar | $1.0M | $8.1M | $13.8M | $11.8M | $7.1M | $7.6M |
| Deuda a Corto | $5.6M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $8.6M | $24.6M | $38.3M | $39.4M | $58.0M | $42.9M |
| Deuda a Largo | 0 | $75.7M | $69.8M | $75.7M | $108.9M | $7.6M |
| Pasivos Totales | $8.6M | $138.1M | $108.1M | $124.0M | $175.3M | $160.6M |
| Reservas | -$23.8M | -$385.7M | -$601.9M | -$752.9M | -$988.7M | -$1.19B |
| Patrimonio Neto | $3.1M | $491.6M | $336.2M | $236.2M | $401.5M | $526.9M |
| Deuda Total | $5.6M | $75.7M | $69.8M | $84.6M | $117.2M | $7.6M |
| Deuda Neta | -$1.6M | -$519.4M | -$323.8M | -$172.0M | -$365.0M | -$287.0M |
| Capital Circulante | $2.5M | $604.1M | $399.4M | $275.7M | $478.4M | $324.9M |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 9.53 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 9.85 |
Rentabilidad
| Rentabilidad sobre capital | -60.37% |
| Rentabilidad sobre capital invertido | -42.41% |
| Rentabilidad sobre activos | -39.05% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: CGEM · CMPX · DSGN · EWTX · GLUE · IPSC · IVA
Explorar sector: Healthcare · Biotechnology
Más secciones de CNTA: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones